Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of PBF-677 in Healthy Young Male Volunteers
NCT02639975Phase 1Completed
- Sponsor
- Palobiofarma
- Start
- Dec 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of PBF-677 in Glaucoma (8 arms), sponsored by Palobiofarma. Primary endpoint: Number of Adverse events at 1 week. Started Dec 2015; status: completed.
02
Drugs
PBF-677
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT02639975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02639975.